A Study Comparing the Efficacy and Safety of CHF 1535 (BDP +FF) Inhalation Powder, Administered Via the NEXT Inhaler, Versus CHF 1535 (BDP +FF), Administered Via a pMDI, in Moderate to Severe Asthma
Clinical trial NCT00862394 · COMPLETED
Trial details
- NCT number
- NCT00862394
- Sponsor
- Chiesi Farmaceutici S.p.A.
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2009-02-01
- Primary completion
- 2009-10-01
- Enrollment
- 783
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.